Clinical Trial Update: Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. [Phase 3]

View source ↗

Summary

A Phase 3 crossover trial compared the pharmacokinetics of once-daily LCP-Tacro tablets with twice-daily generic tacrolimus capsules in renal failure patients; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• LCP-Tacro (tacrolimus)
• Tacrolimus (generic) (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure | Phase 3 | Status: COMPLETED | Results posted: 2016-08-15